Diabetes Injection Pen Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Diabetes Injection Pen Market to 2027 - Global Analysis and Forecasts by Type (Disposable Injection Pens, Reusable Injection Pens); By Therapy (Diabetes, Growth Hormone Therapy, Fertility, Osteoporosis, Other Therapies); By End User (Home care, Hospital and Clinics) and Geography

Report Code: TIPRE00004552 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
MARKET INTRODUCTION
Diabetes is a disease that affect how your body uses blood sugar (glucose). Glucose is important source of energy for the cell that make up your muscles and tissue. Diabetes Injection Pen are medical device which are used to treatment of diabetes. Managing diabetes often required taking insulin shots throughout the day. The diabetes injection pen is used to inject insulin with high accuracy dose form in the body. The diabetes injection pen is known for easier to use and higher dose accuracy.

MARKET DYNAMICS
The diabetes injection pen market is expected to grow during the forecast period due to the changing life style and consumption of unhealthy food, increasing prevalence of diabetes, daily need of consumption of insulin dose. The rising predominance of diabetes in different age category is encourage the growth of diabetes injection pen market. Raising awareness of diabetes treatment will increase diabetes injection pen market. Growing R&D activities is likely to show positive impact on market growth.

MARKET SCOPE
The "Globally Diabetes Injection Pen Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of diabetes injection pen with detailed market segmentation by product type, therapy, end user and geography. The globally diabetes injection pen market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading diabetes injection pen market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global diabetes injection pen market is segmented on the basis of product type, therapy and end user. Based on products type, the market is segmented as disposable injection pen and reusable injection pen. On the basis of therapy, the global diabetes injection pen market is segmented into diabetes growth hormone therapy, fertility, osteoporosis and other therapies. Based on end user, the market segmented into homecare, hospital and clinics.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global diabetes injection pen market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America The diabetes injection pen market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Asthma therapeutics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the global diabetes injection pen market in these regions.

MARKET PLAYERS
The reports cover key developments in the global diabetes injection pen market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from the diabetes injection pen market are anticipated to lucrative growth opportunities in the future with the rising demand for diabetes injection pen market in the global market. Below mentioned is the list of few companies engaged in the global diabetes injection pen market.

The report also includes the profiles of key the global diabetes injection pen market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Novo Nordisk
  • Eli Lilly and company
  • Sanofi
  • Merck & Co., Inc.
  • Ypsomed AG
  • F. Hoffman-La Roche Ltd.
  • BD
  • Pfizer Inc.
  • Haselmeier
  • Owen Mumford
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advance statistical expertise and offer various customization options in the existing study.



TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Diabetes Injection Pens Market - By Type
1.3.2 Diabetes Injection Pens Market - By Therapy
1.3.3 Diabetes Injection Pens Market - By End User
1.3.4 Diabetes Injection Pens Market - By Region
1.3.4.1 by Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. DIABETES INJECTION PENS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DIABETES INJECTION PENS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. DIABETES INJECTION PENS MARKET - GLOBAL MARKET ANALYSIS
6.1. DIABETES INJECTION PENS - GLOBAL MARKET OVERVIEW
6.2. DIABETES INJECTION PENS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. DIABETES INJECTION PENS MARKET - REVENUE AND FORECASTS TO 2027 -TYPE
7.1. OVERVIEW
7.2. BY TYPE MARKET FORECASTS AND ANALYSIS
7.3. DISPOSABLE INJECTION PENS
7.3.1. Overview
7.3.2. Disposable injection pens Market Forecast and Analysis
7.4. REUSABLE INJECTION PENS
7.4.1. Overview
7.4.2. Reusable injection pens Market Forecast and Analysis
8. DIABETES INJECTION PENS MARKET - REVENUE AND FORECASTS TO 2027 -THERAPY
8.1. OVERVIEW
8.2. BY THERAPY MARKET FORECASTS AND ANALYSIS
8.3. DIABETES
8.3.1. Overview
8.3.2. Diabetes Market Forecast and Analysis
8.3.3. Insulin Market
8.3.3.1. Overview
8.3.3.2. Insulin Market Forecast and Analysis
8.3.4. GLP-1 Market
8.3.4.1. Overview
8.3.4.2. GLP-1 Market Forecast and Analysis
8.4. GROWTH HORMONE THERAPY
8.4.1. Overview
8.4.2. Growth hormone therapy Market Forecast and Analysis
8.5. FERTILITY
8.5.1. Overview
8.5.2. Fertility Market Forecast and Analysis
8.6. OSTEOPOROSIS
8.6.1. Overview
8.6.2. Osteoporosis Market Forecast and Analysis
8.7. OTHER THERAPIES
8.7.1. Overview
8.7.2. Other Therapies Market Forecast and Analysis
9. DIABETES INJECTION PENS MARKET - REVENUE AND FORECASTS TO 2027 -END USER
9.1. OVERVIEW
9.2. BY END USER MARKET FORECASTS AND ANALYSIS
9.3. HOME CARE
9.3.1. Overview
9.3.2. Home care Market Forecast and Analysis
9.4. HOSPITAL AND CLINICS
9.4.1. Overview
9.4.2. Hospital and clinics Market Forecast and Analysis
10. DIABETES INJECTION PENS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Diabetes Injection Pens Market Overview
10.1.2 North America Diabetes Injection Pens Market Forecasts and Analysis
10.1.3 North America Diabetes Injection Pens Market Forecasts and Analysis - By Type
10.1.4 North America Diabetes Injection Pens Market Forecasts and Analysis - By Therapy
10.1.5 North America Diabetes Injection Pens Market Forecasts and Analysis - By End User
10.1.6 North America Diabetes Injection Pens Market Forecasts and Analysis - By Countries
10.1.6.1 United States Diabetes Injection Pens Market
10.1.6.1.1 United States Diabetes Injection Pens Market by Type
10.1.6.1.2 United States Diabetes Injection Pens Market by Therapy
10.1.6.1.3 United States Diabetes Injection Pens Market by End User
10.1.6.2 Canada Diabetes Injection Pens Market
10.1.6.2.1 Canada Diabetes Injection Pens Market by Type
10.1.6.2.2 Canada Diabetes Injection Pens Market by Therapy
10.1.6.2.3 Canada Diabetes Injection Pens Market by End User
10.1.6.3 Mexico Diabetes Injection Pens Market
10.1.6.3.1 Mexico Diabetes Injection Pens Market by Type
10.1.6.3.2 Mexico Diabetes Injection Pens Market by Therapy
10.1.6.3.3 Mexico Diabetes Injection Pens Market by End User
10.2. EUROPE
10.2.1 Europe Diabetes Injection Pens Market Overview
10.2.2 Europe Diabetes Injection Pens Market Forecasts and Analysis
10.2.3 Europe Diabetes Injection Pens Market Forecasts and Analysis - By Type
10.2.4 Europe Diabetes Injection Pens Market Forecasts and Analysis - By Therapy
10.2.5 Europe Diabetes Injection Pens Market Forecasts and Analysis - By End User
10.2.6 Europe Diabetes Injection Pens Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Diabetes Injection Pens Market
10.2.6.1.1 Germany Diabetes Injection Pens Market by Type
10.2.6.1.2 Germany Diabetes Injection Pens Market by Therapy
10.2.6.1.3 Germany Diabetes Injection Pens Market by End User
10.2.6.2 France Diabetes Injection Pens Market
10.2.6.2.1 France Diabetes Injection Pens Market by Type
10.2.6.2.2 France Diabetes Injection Pens Market by Therapy
10.2.6.2.3 France Diabetes Injection Pens Market by End User
10.2.6.3 Italy Diabetes Injection Pens Market
10.2.6.3.1 Italy Diabetes Injection Pens Market by Type
10.2.6.3.2 Italy Diabetes Injection Pens Market by Therapy
10.2.6.3.3 Italy Diabetes Injection Pens Market by End User
10.2.6.4 Spain Diabetes Injection Pens Market
10.2.6.4.1 Spain Diabetes Injection Pens Market by Type
10.2.6.4.2 Spain Diabetes Injection Pens Market by Therapy
10.2.6.4.3 Spain Diabetes Injection Pens Market by End User
10.2.6.5 United Kingdom Diabetes Injection Pens Market
10.2.6.5.1 United Kingdom Diabetes Injection Pens Market by Type
10.2.6.5.2 United Kingdom Diabetes Injection Pens Market by Therapy
10.2.6.5.3 United Kingdom Diabetes Injection Pens Market by End User
10.2.6.6 Rest of Europe Diabetes Injection Pens Market
10.2.6.6.1 Rest of Europe Diabetes Injection Pens Market by Type
10.2.6.6.2 Rest of Europe Diabetes Injection Pens Market by Therapy
10.2.6.6.3 Rest of Europe Diabetes Injection Pens Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Diabetes Injection Pens Market Overview
10.3.2 Asia-Pacific Diabetes Injection Pens Market Forecasts and Analysis
10.3.3 Asia-Pacific Diabetes Injection Pens Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Diabetes Injection Pens Market Forecasts and Analysis - By Therapy
10.3.5 Asia-Pacific Diabetes Injection Pens Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Diabetes Injection Pens Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Diabetes Injection Pens Market
10.3.6.1.1 Australia Diabetes Injection Pens Market by Type
10.3.6.1.2 Australia Diabetes Injection Pens Market by Therapy
10.3.6.1.3 Australia Diabetes Injection Pens Market by End User
10.3.6.2 China Diabetes Injection Pens Market
10.3.6.2.1 China Diabetes Injection Pens Market by Type
10.3.6.2.2 China Diabetes Injection Pens Market by Therapy
10.3.6.2.3 China Diabetes Injection Pens Market by End User
10.3.6.3 India Diabetes Injection Pens Market
10.3.6.3.1 India Diabetes Injection Pens Market by Type
10.3.6.3.2 India Diabetes Injection Pens Market by Therapy
10.3.6.3.3 India Diabetes Injection Pens Market by End User
10.3.6.4 Japan Diabetes Injection Pens Market
10.3.6.4.1 Japan Diabetes Injection Pens Market by Type
10.3.6.4.2 Japan Diabetes Injection Pens Market by Therapy
10.3.6.4.3 Japan Diabetes Injection Pens Market by End User
10.3.6.5 South Korea Diabetes Injection Pens Market
10.3.6.5.1 South Korea Diabetes Injection Pens Market by Type
10.3.6.5.2 South Korea Diabetes Injection Pens Market by Therapy
10.3.6.5.3 South Korea Diabetes Injection Pens Market by End User
10.3.6.6 Rest of Asia-Pacific Diabetes Injection Pens Market
10.3.6.6.1 Rest of Asia-Pacific Diabetes Injection Pens Market by Type
10.3.6.6.2 Rest of Asia-Pacific Diabetes Injection Pens Market by Therapy
10.3.6.6.3 Rest of Asia-Pacific Diabetes Injection Pens Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Diabetes Injection Pens Market Overview
10.4.2 Middle East and Africa Diabetes Injection Pens Market Forecasts and Analysis
10.4.3 Middle East and Africa Diabetes Injection Pens Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Diabetes Injection Pens Market Forecasts and Analysis - By Therapy
10.4.5 Middle East and Africa Diabetes Injection Pens Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Diabetes Injection Pens Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Diabetes Injection Pens Market
10.4.6.1.1 South Africa Diabetes Injection Pens Market by Type
10.4.6.1.2 South Africa Diabetes Injection Pens Market by Therapy
10.4.6.1.3 South Africa Diabetes Injection Pens Market by End User
10.4.6.2 Saudi Arabia Diabetes Injection Pens Market
10.4.6.2.1 Saudi Arabia Diabetes Injection Pens Market by Type
10.4.6.2.2 Saudi Arabia Diabetes Injection Pens Market by Therapy
10.4.6.2.3 Saudi Arabia Diabetes Injection Pens Market by End User
10.4.6.3 U.A.E Diabetes Injection Pens Market
10.4.6.3.1 U.A.E Diabetes Injection Pens Market by Type
10.4.6.3.2 U.A.E Diabetes Injection Pens Market by Therapy
10.4.6.3.3 U.A.E Diabetes Injection Pens Market by End User
10.4.6.4 Rest of Middle East and Africa Diabetes Injection Pens Market
10.4.6.4.1 Rest of Middle East and Africa Diabetes Injection Pens Market by Type
10.4.6.4.2 Rest of Middle East and Africa Diabetes Injection Pens Market by Therapy
10.4.6.4.3 Rest of Middle East and Africa Diabetes Injection Pens Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Diabetes Injection Pens Market Overview
10.5.2 South and Central America Diabetes Injection Pens Market Forecasts and Analysis
10.5.3 South and Central America Diabetes Injection Pens Market Forecasts and Analysis - By Type
10.5.4 South and Central America Diabetes Injection Pens Market Forecasts and Analysis - By Therapy
10.5.5 South and Central America Diabetes Injection Pens Market Forecasts and Analysis - By End User
10.5.6 South and Central America Diabetes Injection Pens Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Diabetes Injection Pens Market
10.5.6.1.1 Brazil Diabetes Injection Pens Market by Type
10.5.6.1.2 Brazil Diabetes Injection Pens Market by Therapy
10.5.6.1.3 Brazil Diabetes Injection Pens Market by End User
10.5.6.2 Argentina Diabetes Injection Pens Market
10.5.6.2.1 Argentina Diabetes Injection Pens Market by Type
10.5.6.2.2 Argentina Diabetes Injection Pens Market by Therapy
10.5.6.2.3 Argentina Diabetes Injection Pens Market by End User
10.5.6.3 Rest of South and Central America Diabetes Injection Pens Market
10.5.6.3.1 Rest of South and Central America Diabetes Injection Pens Market by Type
10.5.6.3.2 Rest of South and Central America Diabetes Injection Pens Market by Therapy
10.5.6.3.3 Rest of South and Central America Diabetes Injection Pens Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. DIABETES INJECTION PENS MARKET, KEY COMPANY PROFILES
12.1. NOVO NORDISK
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ELI LILLY AND COMPANY
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. SANOFI
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MERCK & CO., INC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. YPSOMED AG
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ASTRAZENECA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. F.HOFFMAN-LA ROCHE LTD.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. BD
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PFIZER, INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. HASELMEIER
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
12.11. OWEN MUMFORD
12.11.1. Key Facts
12.11.2. Business Description
12.11.3. Products and Services
12.11.4. Financial Overview
12.11.5. SWOT Analysis
12.11.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Novo Nordisk
2. Eli lilly and company
3. Sanofi
4. Merck & Co., Inc.
5. Ypsomed AG
6. F. Hoffman-La Roche Ltd.
7. BD
8. Pfizer Inc.
9. Haselmeier
10. Owen Mumford
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book